Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

Tesla shares fell 0.4% to $447.31 Tuesday after a filing showed senior executive Tom Zhu received a large options grant priced at $435.80. Wolfe Research flagged rising costs and demand risks, projecting 2026 EPS below consensus. Investors await Tesla’s Jan. 28 earnings for updates on margins and software progress. The S&P 500 and Nasdaq also slipped 0.4% after the latest U.S. inflation data.
13 January 2026
··
IBM stock drops 3% even after BofA lifts target — what to watch before earnings

IBM stock drops 3% even after BofA lifts target — what to watch before earnings

IBM shares fell about 3% Tuesday, underperforming a weaker U.S. market after Bank of America raised its price target but warned of a tougher 2026 setup. BofA expects $400 million in restructuring costs to weigh on fourth-quarter margins. Investors await IBM’s January 28 earnings for signals on software growth and cash flow. IBM’s $11 billion Confluent deal remains pending.
13 January 2026
··
Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines

Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines

Oklo shares fell 3.3% to $99.10 in late trading Tuesday after hitting an intraday high of $107.55. The drop followed news of CEO Jacob DeWitte’s insider share sales and updates on Meta-backed nuclear projects in Ohio. Oklo’s agreement with Meta targets a 1.2 GW power campus, with pre-construction work set for 2026. Broader nuclear stocks were mostly flat.
13 January 2026
···
Verizon stock slides after FCC loosens phone-unlocking rule as fraud fight takes center stage

Verizon stock slides after FCC loosens phone-unlocking rule as fraud fight takes center stage

Verizon shares fell 2.5% to $38.86 Tuesday after U.S. regulators scrapped a rule requiring the carrier to unlock phones 60 days after activation. The FCC’s order, effective immediately, follows Verizon’s claim that the rule fueled fraud involving nearly 785,000 devices last year. AT&T and T-Mobile also declined. Verizon separately disclosed changes to a $30 million executive stock award.
13 January 2026
·
Texas Instruments stock slips late in session as CPI hits tape and Jan. 27 earnings loom

Texas Instruments stock slips late in session as CPI hits tape and Jan. 27 earnings loom

Texas Instruments shares fell 0.5% to $188.12 Tuesday, lagging the broader chip sector as investors weighed new U.S. inflation data and awaited the company’s Jan. 27 earnings report. The iShares Semiconductor ETF rose 0.9%, while rivals Analog Devices and ON Semiconductor posted gains. U.S. consumer prices rose 0.3% in December, with core inflation up 2.6% year-over-year.
13 January 2026
·······
Verizon stock drops as FCC loosens phone unlocking rule and traders look to earnings next

Verizon stock drops as FCC loosens phone unlocking rule and traders look to earnings next

The FCC granted Verizon a waiver from its 60-day phone unlocking rule, allowing the carrier to follow broader industry standards. Verizon shares fell 2.4% to $38.89 Tuesday, underperforming peers after the decision. The company reported losing 784,703 devices to fraud in 2023. Verizon also amended a $30 million performance stock award for CEO Daniel H. Schulman.
13 January 2026
··
Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer shares fell 0.6% to $25.12 in Tuesday afternoon trading after CEO Albert Bourla discussed plans to accelerate obesity drug trials at the J.P. Morgan Healthcare Conference. Bourla said Pfizer aims to launch 10 Phase 3 trials for its Metsera portfolio by 2026 but does not expect revenue growth before 2029. Investors await the Feb. 3 earnings report for updates on the obesity pipeline and guidance.
13 January 2026
···
SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi shares rose 1.1% to $26.89 Tuesday afternoon, outperforming a 0.4% drop in the S&P 500 as investors assessed Trump’s proposed 10% cap on credit card interest rates. The policy push has rattled banks and payments firms, who warn it could restrict credit. Wall Street analysts see legal hurdles but say fintech lenders like SoFi could benefit if banks tighten lending. Focus turns to SoFi’s Jan. 30 earnings.
13 January 2026
·
ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow shares fell 3.3% to $137.95 Tuesday after Oppenheimer cut its price target to $200, citing sector concerns ahead of earnings. Goldman Sachs began coverage with a Buy rating and $205 target, while Citi maintained its Buy and placed the stock on a 30-day catalyst watch. The iShares Expanded Tech-Software ETF dropped 2%. Investors remain cautious after ServiceNow’s $7.75 billion Armis acquisition.
13 January 2026
··
AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie shares fell 0.1% to $219.83 Tuesday after announcing a three-year U.S. pricing deal tied to tariff exemptions. The company also signed a $650 million licensing agreement with China’s RemeGen for rights to an experimental cancer drug and bought a manufacturing site in Arizona. Management is set to speak at the J.P. Morgan Healthcare Conference on Jan. 14.
13 January 2026
··
Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam shares fell 0.1% to $370.39 Tuesday afternoon after the company projected 2026 net product revenue between $4.9 billion and $5.3 billion. Preliminary 2025 sales were disclosed at $2.987 billion. Analysts remained mostly positive but flagged possible weakness for Amvuttra next quarter. The update came as Alnylam outlined its new five-year strategy at the J.P. Morgan Healthcare Conference.
13 January 2026
··
1 … 221 222 223 224 225 … 606

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop